ArticleClinical and molecular hepatology2025

Challenges and innovations in primary sclerosing cholangitis clinical trials: Evaluating HK-660S and the path forward: Editorial on "Safety and efficacy of HK-660S in patients with primary sclerosing cholangitis: A randomized double-blind phase 2a trial".

Nilanga NishadPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.